The draft recommendation comes from the U.S. Preventive Services Task Force, whose advisories often guide physician practice and insurance coverage. The guidelines -- which restate a 2013 advisory -- encourage genetic testing only for women with either a family history of breast or ovarian cancer, or an ethnicity or ancestry associated with BRCA1 or BRCA2 mutations.
A leading-edge genetic technique that can track cell lineage has revealed much about how breast cancer spreads. It could also help explain why some breast cancers relapse after initially successful chemotherapy.
A diagnosis of metastatic breast cancer can evoke many difficult emotions, including shock, anger, and sadness. These are all normal reactions. It’s extremely important to allow yourself to experience all your feelings in order to help you move forward and take an active role in your treatment.
Scientists have identified genetic changes that may predict the likelihood of breast cancer relapse in women
A naturally occurring protein, called Tinagl1, suppressed the growth and spread of triple-negative breast cancer (TNBC) in mice